Experimental immune therapy shows promise against deadly childhood brain cancer
Several children who had aggressive recurrent tumors remained disease-free years after the treatment, according to an early stage trial
Several children who had aggressive recurrent tumors remained disease-free years after the treatment, according to an early stage trial